OTHER INFORMATION
−Removed: Amendment to Amended and Restated Bylaws, dated September 21, 2022 (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 23, 2022).
+Added: Engagement Letter, dated as of November 27, 2022, by and between Dermata Therapeutics, Inc.
+Added: Wainwright & Co., LLC.
+Added: (incorporated by reference to Exhibit 1.1 to the Company’s Registration Statement on Form S-1 (File No.
+Added: 333-270195) filed on March 1, 2023).
+Added: Amendment No.
+Added: 1 to the Engagement Letter, dated December 12, 2022, by and between Dermata Therapeutics, Inc.
+Added: Wainwright & Co., LLC.
+Added: (incorporated by reference to Exhibit 1.2 to the Company’s Registration Statement on Form S-1 (File No.
+Added: 333-270195) filed on March 1, 2023).
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Dermata Therapeutics, Inc., dated March 13, 2023.
+Added: (incorporated by reference to Exhibit 3.1 to the Company’s Current Report file on Form 8-K filed on March 13, 2023).
+Added: Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.8 to the Company’s Registration Statement on Form S-1/A (File No.
+Added: 333-270195) filed on March 13, 2023).
+Added: Form of Series A Common Warrant and Series B Common Warrant (incorporated by reference to Exhibit 4.9 to the Company’s Registration Statement on Form S-1/A (File No.
+Added: 333-270195) filed on March 16, 2023).
+Added: Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.10 to the Company’s Registration Statement on Form S-1/A (File No.
+Added: 333-270195) filed on March 13, 2023).
+Added: Form of Purchase Agreement (incorporated by reference to Exhibit 10.23 to the Company’s Registration Statement on Form S-1/A (File No.
+Added: 333-270195) filed on March 16, 2023).
+Added: Amendment No.
+Added: 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc.
+Added: (incorporated by reference to Exhibit 10.14 to the Company’s Registration Statement on Form S-1/A (File No.
+Added: 333-270195) filed March 16, 2023).
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a).
13 unchanged sentences
Dermata Therapeutics, Inc.
−Removed: November 10, 2022
/s/ Gerald T.
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.